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Abstract
Tick-borne encephalitis virus (TBEV) causes human epidemics across Eurasia. Clinical manifestations range from inapparent
infections and fevers to fatal encephalitis but the factors that determine disease severity are currently undefined. TBEV is
characteristically a hemagglutinating (HA) virus; the ability to agglutinate erythrocytes tentatively reflects virion receptor/
fusion activity. However, for the past few years many atypical HA-deficient strains have been isolated from patients and also
from the natural European host tick, Ixodes persulcatus. By analysing the sequences of HA-deficient strains we have
identified 3 unique amino acid substitutions (D67G, E122G or D277A) in the envelope protein, each of which increases the
net charge and hydrophobicity of the virion surface. Therefore, we genetically engineered virus mutants each containing
one of these 3 substitutions; they all exhibited HA-deficiency. Unexpectedly, each genetically modified non-HA virus
demonstrated increased TBEV reproduction in feeding Ixodes ricinus, not the recognised tick host for these strains.
Moreover, virus transmission efficiency between infected and uninfected ticks co-feeding on mice was also intensified by
each substitution. Retrospectively, the mutation D67G was identified in viruses isolated from patients with encephalitis. We
propose that the emergence of atypical Siberian HA-deficient TBEV strains in Europe is linked to their molecular adaptation
to local ticks. This process appears to be driven by the selection of single mutations that change the virion surface thus
enhancing receptor/fusion function essential for TBEV entry into the unfamiliar tick species. As the consequence of this
adaptive mutagenesis, some of these mutations also appear to enhance the ability of TBEV to cross the human blood-brain
barrier, a likely explanation for fatal encephalitis. Future research will reveal if these emerging Siberian TBEV strains continue
to disperse westwards across Europe by adaptation to the indigenous tick species and if they are associated with severe
forms of TBE.
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Introduction
Tick-borne encephalitis virus (TBEV) causes up to 14,000 human
cases of tick-borne encephalitis (TBE) across Eurasia annually [1,2].
TBE outbreaks are now registered in about 30 European countries
with a recorded morbidity increase of about 400% during the past
30 years [3]. TBEV is a member of the tick-borne flavivirus (TBFV)
group that, together with mosquito-borne and no-known vector
virus groups comprise the genus Flavivirus within the family
Flaviviridae. Human pathogens within the genus Flavivirus include
Japanese encephalitis virus, Dengue virus and Yellow fever virus
that cause annual epidemics of fever, encephalitis and hemorrhagic
fever in the tropics and some sub-tropical regions [4,5].
In its natural habitat, TBEV is maintained by transmission
between infected and non-infected ticks when they co-feed on
small forest animals [6–8]. Humans are incidental hosts for ticks
and may become infected by a feeding infected tick. The clinical
manifestations caused by TBEV range from inapparent infections
and fevers, with complete recovery of patients, to debilitating or
fatal encephalitis. The proportion of fatal human infections varies
widely in different regions and in different years. The factors that
determine disease severity are poorly defined but correlations
between viral subtype and disease severity have been described.
TBEV strains are currently divided into 3 closely related subtypes,
i.e. western-European (WE), Siberian (SIB) and Far Eastern (FE)
[9]. FE TBEV is recognised as the most virulent pathogen with a
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20–40% case fatality rate. The SIB subtype is considered less
virulent (7–8% case fatality rate) but chronic disease occurs more
frequently (1–3%). Western European strains are the least virulent
with case fatality rates lower than 2%. However, a range of clinical
manifestations, from asymptomatic to encephalitic is observed for
all TBEV subtypes [1,2] and the underlying basis for this has not
yet been adequately explained.
Conventionally, each TBEV subtype has been associated with
distinct geographic ranges within the Old World region of the
northern hemisphere, hence the groupings Far East, Siberia and
Western Europe [9]. However during recent decades the
epidemiology of the TBFV appears to have been changing, with
SIB TBEV becoming the dominant subtype apparently gradually
replacing the WE or FE subtypes that previously appeared to
monopolise many regions [10–16]. Moreover, the SIB subtype is
being isolated more frequently from patients who develop the most
severe forms of encephalitis, with the virus invading the entire
brain in contrast with the more focal virus localization observed
previously. Over a period of time, the most severe cases of TBE
have been more frequently associated with the SIB strains than
with the FE strains [17], indicating that this is not an artifact of
increased surveillance. Whilst these reports are disturbing they
have not as yet been addressed at the molecular virological level.
TBEV virions are spherical particles with an ,11 kb-RNA
genome embedded in a capsid that is surrounded by a lipid
envelope mainly containing a virus envelope (E) glycoprotein. This
E protein plays a key role in many stages of the virus life cycle; it
mediates virus binding to receptors on the cell surface (adsorption)
which triggers receptor-mediated endocytosis. Exposure of the
endocytosed virus to the acid pH converts the native E protein
dimers into fusogenic trimers [18,19]; the latter promote fusion of
virion and endosomal membranes thus releasing viral RNA into
the cytoplasm. The E protein also plays the major role in inducing
the host immune response and mediates hemagglutination (HA),
i.e. the ability of virions to agglutinate avian erythrocytes; for
decades HA has been used in routine diagnosis [20].
Whilst most strains of TBEV show HA activity, during the past
10 years atypical HA-deficient strains have been isolated with
increasing frequency in Europe from both ticks and infected
patients. More than 40 HA-deficient strains are now recognized
and they all exhibit reduced pathogenicity for mice when
compared with HA-competent strains. They are also called
‘‘antigenically deficient’’ (AD) strains, in contrast to the more
common antigenically competent (AC) strains; the term ‘‘AD’’ is
derived from the strict correlation between loss of HA and
immunoprecipitating activities [21]. The AD-viruses were also
deficient in complement-fixation and neutralization tests when
analysed using either hyperimmune antisera or sera obtained from
patients recovered from TBE [21]. Here, using molecular methods
of analysis, we show that HA-deficiency is linked with the
adaptation of SIB TBEV strains to western European Ixodes ricinus
ticks reflecting altered, E protein-mediated, receptor/fusion
functions. We also illustrate how this might result in continued
westward dispersal and emergence of new highly pathogenic virus
variants (see Fig. S1).
Results
Yar viruses are HA- deficient TBEV strains
Yar-strains of TBEV i.e. Yar71, Yar 114, Yar 46-2, and Yar 48
were isolated in the European part of Russia (Yaroslavl’ region)
between 1999–2001 and details for their isolation are listed in
Table 1. All 4 Yar viruses had equivalent infectivities when
compared with the Vasilchenko (Vs) strain of TBEV (see Methods)
used as the positive control virus (Table 1) and produced
comparable concentrations of E protein when analysed by
Western blot (data not shown). However, they were completely
negative in HA tests over a range of pH 5.75–7, regardless of
whether they were prepared in newborn mice or in PS cells. The
control Vs virus and pGGVs virus, recovered from the infectious
clone (see Methods), produced high positive HA titres (1:640-
1:1280) at pH 6.2 and this was therefore the pH of choice for all
subsequent tests (Table 1). Thus, the 4 Yar isolates can be defined
as HA- or AD-deficient in common with the other 40 strains that
have been isolated in Europe and were also identified as HA- and
AD-deficient [21].
Yar- viruses belong to the ‘‘Baltic’’ group of the Siberian
TBEV subtype
Phylogenetic analyses based on a 1110-bp fragment of the E
gene (positions 1114–2224 in Vs virus L40361) showed that the
Yar-viruses belong to the SIB subtype of TBEV [9,22–26], which
includes the control Vs virus (see Methods). Fig. 1 illustrates the
overall branching pattern in agreement with previously published
results [24,25]. Three Siberian sub-clusters I, II and III were
clearly identifiable and supported by high bootstrap values. Yar-
viruses were grouped with strains of sub-cluster III designated
‘‘Baltic’’ [27], isolated only in Europe, in contrast to strains of
Table 1. TBEV strains used in this study.
Strain
Year of
isolation Source of isolation Passage history Accession No HA test (titers)
Infectivity in PS cells
on 72 h pi (PFU/ml)
Vs 1961 Patient blood Unknown L40361 1:1280 2286106
Yar 71 1999 I. persulcatus 7 in PS EU444077 0 2286106
Yar114 2001 I. persulcatus 4 in PS and 2 in mice EU444078 0 2286106
Yar 46-2 2001 Patient CNS 5 in PS and 2 in mice EU444079 0 2286106
Yar 48 2000 I. persulcatus 5 in PS EU444080 0 2286106
pGGVs 2007 Infectious clone 1 in PS 1:640 2286106
IC-D67G 2007 Infectious clone 1 in PS 0 2286106
IC-E122G 2007 Infectious clone 1 in PS 0 2286106
IC-D277A 2007 Infectious clone 1 in PS 0 2286106
IC-T175N 2007 Infectious clone 1 in PS 1:640 2286106
doi:10.1371/journal.pone.0007295.t001
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clusters I and II that were found across Europe and Asia. Separate
phylogenetic analyses based on the C, prM, E and NS1 genes
produced trees that were congruent with the one presented (data
not shown).
Hemagglutination deficiency results from single amino
acid substitutions on the virion surface
To identify amino acid(s) responsible for the loss of HA-activity,
we sequenced Yar viruses and aligned them with 290 available
TBEV E sequences (Fig. 2A). One amino acid 175N in the E
protein was common to all HA-deficient Yar-viruses, in contrast
with the highly conserved 175T. Therefore, the substitution T for
N at amino acid position 175 was introduced into a TBEV
infectious clone (IC) designated pGGVs [28,29] to generate
mutant virus IC-T175N that produced HA titres similar to parent
Vs virus and also control pGGVs virus rescued from the infectious
clone (Table 1). Since no other common amino acids were
identified that distinguished Yar-viruses from the other strains, we
hypothesised that individual non-shared amino acid substitutions
might be responsible for the HA-deficient phenotype. The
alignment in Fig. 2A revealed 3 non-conserved mutations, each
of which was unique to one of the Yar strains, i.e. D67G (Yar 46-
2), E122G (Yar 71 and Yar 114) and D277A (Yar 48). When
compared with the parent pGGVs virus, each of these mutations
increased net charge and hydrophobicity of the E protein and was
surface orientated, mapping on the most protruding loops of the E
protein in its native dimeric conformation (Fig. 2B).
The loss of HA activity in TBEV has only previously been
reported in relation to selective adaptation of TBEV to ticks. One
substitution, E87K was generated during the propagation of a WE
Figure 1. Phylogenetic analysis of Yar strains. MEGA version 4 [43] was used to align E genes (between nucleotide positions 1114–2223 of Vs
virus genome) of SIB TBEV strains (accession numbers are specified). Tree topology was reconstructed by Neighbor-Joining. The Tamura-Nei model
was used for estimation of evolutionary distances [44]. Bootstraps were based on 1000 replications; values below 90% are hidden. The scale bar
shows the number of nucleotide substitutions per site. Geographic origins of SIB strains and clusters I, II and III are shown on the right hand side of
the tree. Yar strains are highlighted using triangles. KFDV was used as the outgroup.
doi:10.1371/journal.pone.0007295.g001
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strain to I. ricinus ticks [30] and two substitutions, E122G and
T426I respectively, followed a few SIB TBEV passages in H.
marginatum ticks [31]. In support of our observations, the E protein
surface in these independently reported HA deficient viruses, is
predicted to be of either positive or neutral charge, as we have
described for the substitutions, D67G, E122G and D277A
respectively.
Whilst the molecular details of interactions between virions and
erythrocytes remain unknown it has been suggested that HA
activity might be mediated by the trimeric E protein in its post-
fusion conformation rather than by native E dimers [32]. Five of
these trimers form a fusion pore that enables fusion between the
viral and cellular endosomal membrane thus releasing the viral
RNA into the cellular cytoplasm. Therefore we mapped the
chimaeric Yar-simulated mutants onto the crystal structure of the
trimeric (post-fusion) conformation of the E protein [18]. This
demonstrated that the 3 Yar-virus mutations are located along the
most protruding parts of the lateral surface of the trimer (Fig. 2C).
Therefore they are likely to be able to make direct contact with the
erythrocyte surface and/or with each other.
Thus, we hypothesised that each of these three amino acid
substitutions could individually abolish HA deficiency in TBEV.
To test this hypothesis experimentally we used a TBEV infectious
clone to engineer three mutant viruses IC-D67G, IC-E122G and
IC-D277A (See Methods) that simulate the wild-type viruses Yar
46-2, Yar 71/Yar 114 and Yar 48 (Table 1). The introduction of
any one of the three mutations into the parent HA positive pGGVs
virus rendered it HA negative (Fig. 3).
The HA-deficient engineered mutants show slower
growth rates in mammalian cells
All three engineered mutants demonstrated delayed growth in PS
cells, most visible during the first 24 hours (Fig. 4). Nevertheless,
they all subsequently reached titres similar to pGGVs HA-positive
virus by day 3 (Table 1). Although, mutant IC-D67G exhibited
better growth characteristics than IC-E122G and IC-D277A it was
reproducibly slightly lower than the control pGGVs virus.
All 3 natural HA-negative isolates (Yar71, Yar 46-2, and Yar
48) displayed small-plaque phenotype (1 mm, Fig. 4B), in
Figure 2. Identification of HA-disabling mutations. (A). Abbreviated comparative alignment of TBEV E protein sequences (complete version is
available on request). TBEV strains are specified by subtype (FE-, SIB- or WE-subtypes) and GenBank accession numbers. HA-disabling mutations are
encircled. The ‘‘tick-specific’’ amino acids that differentiate I. persulcatus-transmitted viruses (shadowed) from the I. ricinus-transmitted viruses are
highlighted in yellow; those that increase hydrophobicity are boxed and surface-faced amino acids are marked with asterisks (*). The fusion peptide is
underlined. (B) Mapping of HA-disabling residues onto native dimeric conformation of E protein crystal structure [45] (1SVB.pdb); the monomer is
shown as it lies on the virion membrane. The ‘‘persulcatus’’ and ‘‘ricinus’’ residues are highlighted in orange; fusion peptide is in green and HA-
deficient amino acids (arrows) are red. The position of Yar substitution D277A (red coloured) coincides with the position of ‘‘ricinus/persulcatus’’
substitution (orange colour is masked). (C) Residues 67, 122 and 277 (purple spheres) are mapped onto the E protein in trimeric post-fusion
conformation (1URZ.pdb) [18]. The fusion peptide is highlighted in green and can be seen protruding out of the virion membrane towards the
endosomal membrane. Different subunits of the trimer are coloured in red, blue and yellow.
doi:10.1371/journal.pone.0007295.g002
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comparison with control Vs strain which produced much larger
plaques (3 mm) but only two corresponding mutations, E122G
and D277A caused plaque size reduction in the engineered viruses
(0.7 to 1.5 mm as shown in Fig. 4B). Clearly, as yet unidentified
additional mutations contributed to the small plaque phenotype of
Yar 46-2 (D67G). Similarly Yar 48 virus formed smaller plaques
(1 mm) than the corresponding IC-D277A mutant (1.5 mm)
demonstrating that HA activity and plaque phenotype are not
always determined by the same amino acid.
Vs virus is different from many other laboratory-maintained
TBEV strains; in cell culture it develops cytopathic effect (cpe)
relatively slowly [22]. All tested mutants showed no increase or
decrease of cpe in comparison with the control infectious clone
pGGVs, even at high multiplicity of infection (10 PFU/cell).
HA-deficient mutants show reduced TBEV
neuroinvasiveness for mice
After ip inoculation, the control virus pGGVs produced a
relatively high morbidity rate (65%) in correspondence with
previous results [29]. In contrast, all three engineered virus
mutants exhibited lower neuroinvasiveness as determined by
morbidity rates (Fig. 4C). Mice observed for 21 days following ip
inoculation with IC-D67G produced antibodies against TBEV,
indicating that they had been infected (data not shown).
HA-deficiency correlates with increased TBEV
reproduction in feeding ticks and tick-to-tick
transmission efficiency
Studies on the reproduction and tick-to-tick transmission
efficiency of IC-D67G, IC-E122G and IC-D277A were carried
out using a novel tick/mouse laboratory model initially developed
by Labuda et al [7]. In the first set of experiments, 30 ticks were
infected by injection in the leg with each engineered virus as
described in Methods and TBEV titres in salivary glands were
measured in each of 6 ticks at each time point, i.e. on 2nd, 7th, 14th
and 21st day following infection. The reproduction characteristics
of IC-E122G and IC-D277A in fasting ticks were similar to those
of control pGGVs virus whereas the titres of IC-D67G were
significantly lower (Fig. 5A).
On the 21st day post-infection, fasting infected ticks were
allowed to feed on mice and virus titres were measured in each of 6
individual ticks. This analysis was employed for each engineered
virus, 3 days after feeding. Fig. 4A shows that infectivity of IC-
E122G had increased approximately 1000-fold and IC-D277A
and IC-D67G had increased approximately 300-fold, whereas for
control pGGVs virus the increase of virus titre was about 10-fold.
Since 6 ticks were used for each tested virus for each time-point,
the differences in titres between different virus mutants were
statistically significant, based on Student t-tests (p,0.05).
In the second set of experiments, the efficiency of virus
transmission from infected adult female ticks to uninfected nymphs
during co-feeding on mice (tick-to-tick transmission; see Methods)
was evaluated by estimating the proportion of infected nymphs. In
addition, the titres of virus in each recipient nymph were estimated
in a plaque assay. The results show in each case, that HA
deficiency directly correlated with increased TBEV titres in
nymphs, following feeding and also tick-to-tick transmission
efficiency (Fig. 5B).
Analysis of non-conserved amino acid substitutions on
the virion surface
We analysed 290 TBEV E protein sequences for the presence of
amino acid substitutions similar to those that resulted in the loss of
HA in TBEV, i.e. acidic (positively charged) residues that were
replaced by hydrophobic and/or neutral amino acids (i.e. glycine)
and localized on the virion envelope protein surface (Table 2). In
total, 5.8% (including Yar-viruses) of the strains exhibited similar
mutations. Strains with potentially increased charge and/or
surface hydrophobicity were identified in all three TBEV subtypes,
i.e. FE, SIB and WE; they were isolated from different
geographical regions and a variety of hosts including ticks, rodents
and humans.
Notably, the substitution D67G was detected in 7 viruses
isolated only from mammalian hosts and human patients. No
other correlation between isolation source, geography or virus
subtype specificity was observed. A significant number of TBEV E
proteins have been sequenced partially (227 viruses of 290
available from GenBank), therefore it could not be excluded that
TBEV strains with increased surface charge/hydrophobicity are
quite common in nature. Indeed among 63 completely sequenced
E proteins those with increased charge/hydrophobicity on the
virion surface comprise ,20% (including Yar viruses).
We also compared E proteins of TBEV strains isolated from I.
ricinus (WE-strains) with those isolated from I. persulcatus (FE- and
SIB-strains), to identify group amino acids that might be involved
in TBEV adaptation to these two different tick species (Fig. 2A).
Ten amino acid differences were revealed that have previously
been localised in hypervariable clusters of the envelope protein
[33] and five showed overall increased E protein hydrophobicity in
the I. ricinus–transmitted WE-strains in contrast with FE-and SIB-
strains (Fig. 2A). Four of these ten substitutions were localised on
the virion surface, with two (S47A and S88G) increasing the
surface hydrophobicity of ‘‘ricinus’’ strains and two (D178E and
D277E) being conserved (Fig. 2B). Remarkably, the position of the
‘‘tick’’-specific (i.e. I. ricinus or I. persulcatus) D277E amino acid
substitution overlapped with the D277A substitution of Yar 48
(Figs. 2A and 2B). Two substitutions that also increased the
hydrophobicity of strains adapted to I. ricinus were localised either
inside the E protein (T115A) or on the membrane-oriented side
(S267A), i.e. under the virion surface. Four substitutions (T427A,
T431S, V433I and L437V) were located in the transmembrane
domain of the E protein, with one (T427A) more hydrophobic for
‘‘ricinus’’ strains. Louping ill virus (LIV), a TBEV-related virus
which is transmitted by I. ricinus in the UK, also showed the same
more hydrophobic pattern and localisation of ‘‘tick-specific’’
amino acids as the I. ricinus-transmitted WE TBEV strains
(Fig. 2A).
Figure 3. Effect of Yar-virus simulated mutations on HA activity
of TBEV. The engineered viruses IC-D67G, IC-E122G, IC-D277A and
pGGVs (1246107 PFU/well) were tested for HA using chicken
erythrocytes at pH 6.2.
doi:10.1371/journal.pone.0007295.g003
Non-Hemagglutinating Viruses
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Discussion
TBE is currently reported in more than 30 countries of Eurasia
and causes significant outbreaks of encephalitis in 16 countries,
including 13 EU Member States (Austria, the Czech Republic,
Estonia, Finland, Germany, Greece, Hungary, Latvia, Lithuania,
Poland, Slovak Republic, Slovenia, Sweden) and three non-EU
Member States (Norway, Russia and Switzerland) [3]. The clinical
manifestations of TBE in endemic regions vary widely, from
inapparent and febrile infections, with recovery of patients, to
debilitating or fatal encephalitis, even in some vaccinated
individuals [1,2] and no adequate explanations have as yet been
produced.
Here, we have investigated the molecular mechanisms and
epidemiological implications of the emergence of unusual TBEV
strains originally identified as HA- or AD-deficient [21]. In
contrast with most TBEV strains, these novel viruses fail to
agglutinate avian erythrocytes, show reduced antigenic character-
istics and replicate relatively poorly in mammalian cells. We
demonstrated that these strains display increased hydrophobicity
and positive charge on their virion surface. By engineering
genetically modified viruses we proved that these distinct surface
Figure 4. Effect of HA-disabling mutations on growth characteristics of TBEV in mammalian models. (A) Confluent monolayers of PS
cells were infected with IC-D67G, IC-E122G, IC-D277A or pGGVsH virus at an estimated moi of 1 PFU/cell and virus yield in cell culture medium was
determined at different time points post-infection by plaque assay. (B) Plaque morphology of specified Yar viruses and engineered mutants in PS cell
monolayers. (C) Adult mice were inoculated intraperitoneally with 2000 PFU of IC-D67G, IC-E122G, IC-D277A or pGGVsH followed by monitoring of
the morbidity rate (neuroinvasiveness test).
doi:10.1371/journal.pone.0007295.g004
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characteristics, including HA-deficiency, are caused by any one of
three single amino acid substitutions D67G, E122G or D277A in
the E protein. These mutations significantly increased virus
reproduction in feeding ticks and increased the efficiency of tick-
to-tick virus transmission when infected and uninfected ticks co-fed
on the same animal. Thus mutations leading to HA- and AD-
deficiency are directly associated with selection for enhanced virus
transmission between ticks, a process that facilitates virus survival
in the natural habitat [7].
Although I. ricinus ticks can be routinely maintained in
laboratories, SIB TBEV is normally associated with transmission
by I. persulcatus, which is not as readily available for laboratory
experiments. Nevertheless, WE TBEV strains show ,100%
transmission efficiency in their natural tick vector I. ricinus
(manuscript in preparation). Thus, logically, Yar viruses (i.e. SIB
TBEV strains) should be transmitted efficiently in their natural
vector I. persulcatus. Geographically, I. ricinus and I. persulcatus
overlap in Europe and numerous reports describe the isolation of
Siberian strains from I. ricinus which is now recognised as a second
vector for SIB TBEVs [11,34]. We therefore propose that the
driving force behind the westward dispersal of these HA-deficient
strains is their adaptation to newly-encountered European I. ricinus
ticks. This hypothesis is also supported by our analysis of E protein
comparative alignments between FE, SIB and WE subtypes that
revealed more hydrophobic ‘‘ricinus’’ amino acid patterns,
compared with ‘‘persulcatus’’, in correspondence with tick
preference of WE or FE/SIB strains respectively. Louping ill virus,
which is transmitted by I. ricinus in the UK, shares this ‘‘more
hydrophobic’’ pattern with the WE TBEVs.
For many viruses, HA-activity is recognised as a reflection of
receptor [35–37] or low-pH dependent fusion activity [38,39]. It
was suggested that HA activity of flaviviruses is mediated by fusion
activity of the E protein [32] because it is optimal at pH 6.2 which
promotes conversion of native E protein dimers into fusion-active
trimers [18,19]. This implies that the Yar mutations identified
herein destabilise trimer-trimer contacts or contact between
trimers and erythrocyte membranes, thus preventing HA activity.
Alternatively, these mutations may impact on both E protein
functions, ie virus adsorption to the cell surface and pH-dependent
fusion of virions with endosomal membranes.
Therefore, depending on charge and hydrophobicity, tick cell
receptors may restrict ‘‘easy’’ entry of WE-strains into I. persulcatus
or SIB-strains into I. ricinus. Clearly these barriers to infection are
not absolute since Vs virus (SIB TBEV) has a limited capacity to
replicate in I. ricinus (Fig. 5). Phylogenetic analysis also supports
our hypothesis; it was proposed that WE-strains diverged from
ancestral FE- and SIB lineages [40], implying that the emergent
WE subtype adapted to I. ricinus from I. persulcatus by evolving a
more hydrophobic E protein (Fig. 2). The coincidence of increased
hydrophobicity of the virion surface for I. ricinus-adapted WE-
strains and SIB Yar viruses presumably reflects a similar molecular
requirement for different viruses to adapt to the same host.
Alternatively, the emergence of the atypical Yar viruses may result
from adaptation of TBEV to both tick species. Indeed SIB TBEV
strains have been isolated from both I. ricinus and I. persulcatus on
numerous occasions [11,34] and regular switching between them
cannot be excluded. These data might explain the apparently
increasing dissemination of SIB TBEV in Europe; in a few decades
this virus could reach more western territories, possibly even the
UK where I. ricinus is the vector for the Louping ill virus that is
closely related to TBEV.
The mutant IC-D67G was distinct from other HA-deficient
TBEV strains since there was no obvious correlation between loss of
HA activity and significantly reduced growth in mammalian cells.
Figure 5. Effect of HA-disabling mutations on TBEV replication
in ticks. (A) Adult unfed I. ricinus females were infected with IC-D67G, IC-
E122G IC-D277A or pGGVsH virus (day 0) and virus yield (lgPFU/ml; solid
bars) was determined after incubation of infected fasting ticks for 2, 7, 14
and 21 days and also following the transfer of 21-day fasting ticks to feed
on the mice for 3 days. (B) For tick-to-tick transmission, adult infected
ticks were placed on mice in close proximity to uninfected nymphs and
allowed to co-feed for 3 days. Tick-to-tick transmission rate (clear bars) is
expressed as the proportion of infected nymphs to the total number of
nymphs. Black triangles show the average virus titres in individually
infected recipient nymphs as determined by plaque assay.
doi:10.1371/journal.pone.0007295.g005
Non-Hemagglutinating Viruses
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The Yar 71 virus, with the corresponding D67G mutation was
isolated from a fatally infected individual (Table 1) and ominously,
similar substitutions have also been detected in other TBEV isolates
from hospitalised patients with encephalitis (Table 2). It is possible
that due to altered surface charge and hydrophobicity, strains with
D67G might be more able to penetrate the human blood-brain
barrier (neuroinvasiveness) or more rapidly spread between human
neurones, with no correlation to reduced mouse neuroinvasiveness.
This would explain the recently discovered association of the most
severe form of human encephalitis with the SIB strains [17].
The molecular basis of antigenic deficiency of Yar viruses has not
been elucidated but it might be related to the increased incidence of
the most severe forms of TBE having been associated with SIB
subtype [17]. Clearly more studies are required before we can
understand, at the molecular level, the implications of the
phenomenon of HA- and AD-deficiency in terms of the development
of TBE from fever to encephalitis as an interplay between virus
neuroinvasiveness and ability to evade the immune response.
Thus, the emergence of HA-deficient TBEV mediated by
adaptation to different tick species might represent a mechanism
for the westward dissemination of SIB TBEV, increased TBE
incidence in Europe, andmight also be the reason for encephalitis in
humans (see Fig. S1). To confirm and develop these ideas, future
research should focus on large-scale genomics and transmission
studies of TBEV isolates recovered from patients and ticks.
Methods
Viruses, cells, ticks and antisera
Porcine embryo kidney cells (PS) were used to produce TBEV
stocks, to recover mutant viruses, for plaque assay and studies of
cytopathogenicity. Yar-strains of TBEV i.e. Yar71, Yar 114, Yar
46-2, and Yar 48 were isolated in the European part of Russia
(Yaroslavl’ region) between 1999–2001 (Table 1) and stored as
10% mouse brain suspensions. SIB TBEV strain Vasilchenko (Vs)
and its infectious clone (pGGVs) used as control viruses have been
described previously [22,28]. I. ricinus ticks were bred in the
Institute of Zoology, Slovak Academy of Science, Bratislava [7].
RNA extraction, reverse transcription (RT), PCR and
sequencing of Yar viruses
The RNA of each Yar virus was extracted from 200 ml of 10%
infected mouse brain suspension or infected PS cell supernatant
using Total RNA Isolation System (PROMEGA). The RT-PCR
was used to amplify the 59-C-prM-E gene region of Yar viruses as
described [28,41]. PCR products were directly sequenced using a
Taq BigDye Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems). Sequences of the C-prM-E region of Yar-viruses were
deposited in GenBank with accession numbers EU444077,
EU444078, EU444079 and EU444080 (Table 1).
Phylogenetic analysis
Nucleotide and deduced amino acid sequences were aligned
using program package BioEdit [42]. Phylogenetic analyses were
conducted using MEGA4 [43]. Tree topology was reconstructed
by the Neighbor-Joining method and the Tamura-Nei model was
used for estimation of genetic distances [44]. The reliability of the
tree was evaluated by bootstrapping based on 1000 replications.
Mapping of amino acid substitutions on the crystal
structure of the TBEV E protein
The unique amino acid substitutions in the E protein of each
Yar virus were mapped onto the crystal structure of the native
dimeric [45] or low-pH induced trimeric [18] conformation
(1SVB.pdb and 1URZ.pdb respectively ) using PyMOL program
(DeLano, W.L. The PyMOL Molecular Graphics System (2002)
on World Wide Web http://www.pymol.org).
Table 2. The amino acid substitutions of E protein of TBEV strains (290 viruses were analyzed) that resulted in the change of net
charge and/or hydrophobicity of virion surface E-gene.
Mutation TBEV strain Accession No
TBEV
subtype Source of isolation
Region of
isolation Clinical manifestations (if known)
D67G Est2546 DQ393779 FE Field mouse Estonia
D67G T-blood AF091019 FE TBE patient Ural Meningoencephalitis
D67G Ural-Nina FJ214119 FE TBE patient Ural Meningoencephalitis
D67G Ural-P FJ214118 FE TBE patient Ural
D67G Ural-B FJ214117 FE TBE patient Ural
D67G Ural-A FJ214115 FE TBE patient Ural
D67G Volkhov-K FJ214114 FE TBE patient Europe Chronic encephalitis
D67N RK 1424 AF091016 FE I. persulcatus Latvia
E84K 1486 EF469755 SIB I. persulcatus Siberia
E84G 4387/7 X76608 WE I .ricinus Slovakia
E122G DXAL5 AY178833 FE Not specified China
E122G KrM219 DQ988684 WE Rodents Korea
E155G 272-75 AF231806 SIB Vole Siberia
E170G Koltsovo-29 AF540032 FE TBE patient Siberia
D203G DXAL-12 EU089977 FE Not specified China
D203G DXAL-13 EU089976 FE Not specified China
D203G DXAL-21 EU089980 FE Not specified China
doi:10.1371/journal.pone.0007295.t002
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Cytopathic effect (cpe), plaque assay and virus growth
cycles in PS cells
The routine protocols for cpe, plaque assay and growth curve
experiments were described in detail previously [25,28,29,41].
Briefly, for cpe and growth curve experiments PS cells in 24-well
plates were infected with viruses at a multiplicity of infection (moi)
of 1 PFU/cell, in four replicates. To estimate cpe, the inoculum
was replaced with RPMI medium after virus adsorption for 1 h at
37C. Infected cell monolayers were initially examined by
microscopy and then stained with 0.1%naphthalene black at 24,
48, 72, 96 or 120 h post-infection for further examination of the
extent of cpe. For plaque assay, original virus stocks were 10-fold
serially diluted and after 1-h of virus adsorption at 37uC infected
monolayers were overlaid with 1% SeaPlaque Agarose (Cambrex,
USA). After incubation at 37uC for 5 days monolayers were fixed
with 10% formol saline and stained with 0.1% naphthalene black.
For virus growth curve experiments, after virus adsorption for 1-h
at 37uC, monolayers were washed 5 times with serum-free RPMI
medium and overlaid with 1 ml of medium containing 2% FCS.
The supernatant medium from infected cells was collected at 2, 10,
12, 16, 20 and 24 hours pi and frozen at 270uC. The titres of
infectious virus were determined by plaque assay.
Hemagglutination assay
PS cells were infected at a moi of 0.1 PFU/cell in 500 ml
culture flasks and infectious supernatant medium was collected at
day 5pi. The TBEV virions with estimated initial virus titers of
2286106 PFU/ml were concentrated 100 times using 7%
polyethylene glycol (PEG) in the presence of 2.4% NaCl overnight
at 4uC and precipitated by centrifugation at 8000 rpm for 3 h.
The resulting pellet was resuspended in 500 ml of PBS. For routine
hemagglutination test [20,46], 50 ml of the concentrated virus
sample (108 PFU/ml) were placed in the first well of 96-well plates
and diluted two-fold in borate buffer (pH 9.0). Then 100 ml of a
suspension of 0.5% newborn chick erythrocytes was added to each
well. Results are recorded as the reciprocal of the maximum virus
dilution that produced agglutination.
Introduction of mutations into the infectious clone
The ligation in vitro of two overlapping plasmids, pGGVs660–1982H
and pGGVs660–1982del produces full-length infectious clone of TBEV
strain Vs [28,29]. The megaprimer-mediated domain swapping
mutagenesis technique [47] was utilized to introduce point
mutations in pGGVs660–1982H (Fig. 6). For the Hi-Fi PCR, a pair
of primers was used to amplify regions of about 200 nucleotides
(megaprimer); one primer contained the appropriate point mutation
within the E gene. Subsequently, the megaprimer was used to
amplify the pGGVs660–1982H template in 15 cycles of circular PCR
at 95uC for 30 sec, at 60uC for 30 sec and at 72uC for 5 min. Each
cycle of the PCR produced nicked dsDNA molecules, with nascent
(circular) DNA strand originating from template bacterial dsDNA
and the other one (nicked) from newly amplified PCR product.
Following 15 cycles, the accumulation of amplified linear comple-
mentary ssDNA strands resulted in the formation of annealed
circular (twice nicked) molecules. To facilitate screening, the dam-
methylated bacterial (template) DNA was digested with 40 U of
DpnI (New England Biolabs) at 37uC for 1 h. Following this, PCR
products were electroporated into AbleK bacterial cells (Stratagene)
and selected clones were completely sequenced.
Recovery of mutant viruses
To recover engineered viruses, the mutated plasmids, con-
structed on the basis of pGGVs660–1982H, were ligated with
pGGVs660–1982del to restore the full-length cDNA of TBEV as
described previously [29]. Each mutant full-length clone was
subsequently linearised by Sma I and used for SP6 transcription to
produce full-length RNA. The SP6-transcribed RNA was
transfected into PS cells using Lipofectin reagent (Invitrogen)
according to the manufacturer’s protocols. Infectious supernatant
medium was collected on day 5 pi. The presence of virus in
infected cells was confirmed by immunofluorescence microscopy
using monoclonal antibodies specific for flavivirus E proteins [46]
and by RT-PCR. The entire E-gene was sequenced to ensure no
additional substitutions appeared during the genetic manipulation
or initial virus replication in PS cells.
TBEV replication in ticks and co-feeding transmission
Unfed adult females of I. ricinus ticks were inoculated with virus
under a stereo zoom microscope (Wild M 400, Wild Heerbrugg
AG, Switzerland) into the coaxial plate of the second pair of legs
using a digital microinjector TM system (MINJ-D-CE; Tritech
Research, Inc.; USA). Clean nitrogen served as a gas source to
produce an injection pressure of 20 psi ( = app. 1.38bar). The
injection interval was set to 1.0 sec. Hollow glass needles with a
microscopically fine tip were prepared using a P-30 Micropipette
puller (Sutter Instrument Company, USA).
To investigate virus reproduction in fasting ticks, groups of 45 female
ticks were infected with 500 PFU/tick of one TBEV strain. Infected
ticks were incubated at room temperature (2464uC) and 85–90% RH
in a desiccator for 21 days. At 2, 7, 14 and 21 days pi salivary glands of
6 ticks were dissected, individually homogenized and the concentration
of infectious virus was estimated by plaque titration.
Virus tick-to-tick transmission experiments were carried out
essentially as described previously [6–8]. Two of 45 infected adult
female ticks were allowed to feed simultaneously on Balb/C mice
for 3 days with 15 uninfected I. ricinus nymphs that were attached
in close proximity (1–1.5 cm) to the feeding donor females.
Surviving nymphs and salivary glands of donor females were used
to determine the titres of infectious virus using plaque assays. The
co-feeding transmission rate was estimated as the proportion of
nymphs (%) that became infected.
Experimental animal procedures were performed in accordance
with the guidelines for care and maintenance of animals (Act of the
Government of the Slovak Republic 2003 regulating the use of
experimental animals). All animal experiments were approved by
the State Veterinary and Food Administration of the Slovak
Republic (permission numbers 12284/03-220 and 2362/06-221).
The ethical permission to carry out the work with mice was
obtained from the Ethical Review Committee of the Institute of
Virology, Slovak Academy of Sciences’’.
Neuroinvasiveness tests in mice
Ten adult ICR mice were inoculated intraperitoneally (ip) with
2000 PFU/mouse. Mice were observed for 21 days and morbidity
rate was estimated as the proportion of animals that showed
clinical symptoms that included hind-leg paralysis. Sick and
healthy mice were tested for the presence of anti-TBEV antibodies
by HA-inhibition test [20].
Statistical analysis
Statistical analysis was performed on the data obtained from
virus replication studies in PS cells and ticks, neutralization and
neuroinvasiveness test using EXCEL and SigmaPlot 11 software
(Systat Software Inc., USA). Standard errors of mean (SEM) were
estimated for each dataset. Between-groups comparisons were
performed using unpaired, two-tailed Student’s t-test. Values of
p,0.05 were considered as significant.
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Figure 6. Mutagenesis of the infectious clone of TBEV. The plasmid pGGVs660–1982H [29] that contains the partial PrM-E gene fragment
between nucleotides 660–1882 of the Vs virus genome was used as a template in PCR to synthesize megaprimers E-1171 A/G (genome positions and
lengths are specified). Primers used to produce megaprimers, with targeted mutations (circles) are represented by thick arrows. Subsequently the
megaprimer without the other pair of primers was used to amplify plasmid pGGVs660–1982H (solid circular line). The produced linear newly-
synthesized complementary ssDNA molecules (nicked circular dotted line) with acquired mutations were annealed during the last step of PCR,
randomly producing twice-nicked circular DNA. Parent Dam+ methylated DNA of the pGGVs660–1982H was removed by DpnI endonuclease digestion
to facilitate clone selection.
doi:10.1371/journal.pone.0007295.g006
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Supporting Information
Figure S1 Cartoon illustrating the molecular mechanisms of
emergence of new strains of TBEV with possible pathogenic
characteristics for humans.
Found at: doi:10.1371/journal.pone.0007295.s001 (10.14 MB
TIF)
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